Sleeve lobectomy versus lobectomy after neoadjuvant chemo-immunotherapy for non-small cell lung cancer invading the lobar bronchial orifice: a multicenter retrospective cohort study
Lobectomy could be feasible for pCR patients and there is survival advantage with sleeve lobectomy in patients failing to achieve pCR after neoadjuvant chemo-immunotherapy.
Authors
- Ran Ma (ORCID: https://orcid.org/0000-0003-3373-7802)
- Yao Feng (ORCID: https://orcid.org/0000-0001-7923-8158)
- Jiayi Wang
- Pingping Song (ORCID: https://orcid.org/0000-0002-3732-4776)
- Guodong Zhang (ORCID: https://orcid.org/0009-0002-3481-8145)
- Tianyue Ma (ORCID: https://orcid.org/0000-0003-0155-1317)
- Haitang Yang (ORCID: https://orcid.org/0000-0002-8732-5910)
- Jun Yi
- Hao Zhang (ORCID: https://orcid.org/0000-0002-2926-737X)
- Yong Ge
- Hao Peng (ORCID: https://orcid.org/0000-0002-5527-9542)
- Shuyuan Li
Institutions
- Xuzhou Medical College (CN)
- Shanghai Jiao Tong University (CN)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Shanghai Chest Hospital (CN)
- Shandong First Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tlcr-24-925
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00